318 related articles for article (PubMed ID: 26723922)
1. Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Chylothorax and Chylous Ascites in Cirrhosis: A Case Report and Systematic Review of the Literature.
Tsauo J; Shin JH; Han K; Yoon HK; Ko GY; Ko HK; Gwon DI
J Vasc Interv Radiol; 2016 Jan; 27(1):112-6. PubMed ID: 26723922
[TBL] [Abstract][Full Text] [Related]
2. Transjugular intrahepatic portosystemic shunt creation as treatment for refractory chylous ascites and chylothorax in a patient with cirrhosis.
Kinney TB; Ferrara SL; Miller FJ; Roberts AC; Hassanein T
J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 1):85-9. PubMed ID: 14709693
[TBL] [Abstract][Full Text] [Related]
3. Transjugular intrahepatic portosystemic shunt for treatment of cirrhosis-related chylothorax and chylous ascites: single-institution retrospective experience.
Kikolski SG; Aryafar H; Rose SC; Roberts AC; Kinney TB
Cardiovasc Intervent Radiol; 2013 Aug; 36(4):992-7. PubMed ID: 23207657
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunt in refractory chylothorax due to liver cirrhosis.
Lutz P; Strunk H; Schild HH; Sauerbruch T
World J Gastroenterol; 2013 Feb; 19(7):1140-2. PubMed ID: 23467463
[TBL] [Abstract][Full Text] [Related]
5. [Management of chylous ascites and chylothorax. Report of one case].
Jofré P; Grassi B; Benítez C
Rev Med Chil; 2020 Aug; 148(8):1202-1206. PubMed ID: 33399787
[TBL] [Abstract][Full Text] [Related]
6. Cirrhosis related chylous ascites successfully treated with TIPS.
de Vries GJ; Ryan BM; de Bièvre M; Driessen A; Stockbrugger RW; Koek GH
Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):463-6. PubMed ID: 15756102
[TBL] [Abstract][Full Text] [Related]
7. Refractory Chylous Ascites with Chylothorax and an Umbilical Hernia in a Patient Ineligible for a Transjugular Intrahepatic Portosystemic Shunt.
Fatah A; Audiyanto T
Am J Case Rep; 2020 Aug; 21():e925026. PubMed ID: 32865187
[TBL] [Abstract][Full Text] [Related]
8. Refractory chylothorax in hepatic cirrhosis: successful treatment by transjugular intrahepatic portosystemic shunt.
Vignaux O; Gouya H; Dousset B; Mazuir E; Buffet C; Calmus Y; Legmann P
J Thorac Imaging; 2002 Jul; 17(3):233-6. PubMed ID: 12082377
[TBL] [Abstract][Full Text] [Related]
9. Thoracic duct-cutaneous fistula in a patient with cirrhosis of the liver: successful treatment with a transjugular intrahepatic portosystemic shunt.
Rosser BG; Poterucha JJ; McKusick MA; Kamath PS
Mayo Clin Proc; 1996 Aug; 71(8):793-6. PubMed ID: 8691901
[TBL] [Abstract][Full Text] [Related]
10. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
Strunk H; Marinova M
Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
[TBL] [Abstract][Full Text] [Related]
11. Transjugular Intrahepatic Portosystemic Shunt Placement During Pregnancy: A Case Series of Five Patients.
Ingraham CR; Padia SA; Johnson GE; Easterling TR; Liou IW; Kanal KM; Valji K
Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1205-10. PubMed ID: 25613670
[TBL] [Abstract][Full Text] [Related]
12. Chylous ascites in cirrhosis: a case report and review of the literature.
Cheng WS; Gough IR; Ward M; Croese J; Powell LW
J Gastroenterol Hepatol; 1989; 4(1):95-9. PubMed ID: 2490947
[TBL] [Abstract][Full Text] [Related]
13. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
[TBL] [Abstract][Full Text] [Related]
14. Time-Harmonic Elastography of the Liver is Sensitive to Intrahepatic Pressure Gradient and Liver Decompression after Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation.
Tzschätzsch H; Sack I; Marticorena Garcia SR; Ipek-Ugay S; Braun J; Hamm B; Althoff CE
Ultrasound Med Biol; 2017 Mar; 43(3):595-600. PubMed ID: 27979668
[TBL] [Abstract][Full Text] [Related]
15. Chylous ascites and chylothorax due to constrictive pericarditis in a patient undergoing haemodialysis.
Riza Altiparmak M; Avsar S; Yanik S
Neth J Med; 2004 Feb; 62(2):59-61. PubMed ID: 15127833
[TBL] [Abstract][Full Text] [Related]
16. [Chylous ascites and TIPS].
Vargas L; Lobo S; Agar S; Rodríguez A; Soto JR
Rev Med Chil; 1997 Feb; 125(2):220-1. PubMed ID: 9430944
[No Abstract] [Full Text] [Related]
17. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
[TBL] [Abstract][Full Text] [Related]
18. Use of orlistat (xenical) to treat chylous ascites.
Chen J; Lin RK; Hassanein T
J Clin Gastroenterol; 2005 Oct; 39(9):831-3. PubMed ID: 16145348
[TBL] [Abstract][Full Text] [Related]
19. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
Teng D; Zuo H; Liu L; Dong J; Ding L
Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
